Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LEGN

Legend Biotech Corp ADR

Dec 12 • 04:00PM ET

35.49

Dollar change -0.35
Percentage change -0.98	%

Healthcare • Biotechnology • USA • NASD

Peers: GILD CRSP BMY BLUE ALLO EDIT FATE CLLS NTLA SGMO

| Held by: IBB IEMG EEMV MCHI EEM IXUS SPEM GNOM ACWV KOMP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.91	Insider Own	0.83%	Shs Outstand	183.45M	Perf Week	-14.81%
Market Cap	6.51B	Forward P/E	-	EPS next Y	-0.38	Insider Trans	0.00%	Shs Float	181.93M	Perf Month	-11.67%
Income	-348.13M	PEG	-	EPS next Q	-0.25	Inst Own	49.82%	Short Float	13.09%	Perf Quarter	-29.46%
Sales	520.18M	P/S	12.52	EPS this Y	41.50%	Inst Trans	-0.59%	Short Ratio	17.04	Perf Half Y	-18.73%
Book/sh	6.08	P/B	5.83	EPS next Y	55.27%	ROA	-19.47%	Short Interest	23.81M	Perf Year	-42.88%
Cash/sh	6.61	P/C	5.37	EPS next 5Y	-	ROE	-28.35%	52W Range	35.52 - 70.13	Perf YTD	-41.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-168.48%	ROI	-23.87%	52W High	-49.39%	Beta	0.09
Dividend TTM	-	Quick Ratio	4.90	Sales past 5Y	50.60%	Gross Margin	58.66%	52W Low	-0.08%	ATR (14)	2.12
Dividend Ex-Date	-	Current Ratio	4.98	EPS Y/Y TTM	35.99%	Oper. Margin	-67.52%	RSI (14)	29.48	Volatility	6.15% 5.26%
Employees	1826	Debt/Eq	0.31	Sales Y/Y TTM	122.96%	Profit Margin	-66.92%	Recom	1.23	Target Price	80.56
Option/Short	Yes / Yes	LT Debt/Eq	0.31	EPS Q/Q	-99.62%	Payout	-	Rel Volume	1.02	Prev Close	35.84
Sales Surprise	11.32%	EPS Surprise	-3.12%	Sales Q/Q	66.86%	Earnings	Nov 12 BMO	Avg Volume	1.40M	Price	35.49
SMA20	-12.23%	SMA50	-17.57%	SMA200	-28.10%	Trades		Volume	1,422,904	Change	-0.98%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Redburn Atlantic	Buy	$86
Jun-17-24	Initiated	Truist	Buy	$88
May-24-24	Reiterated	H.C. Wainwright	Buy	$86 → $73
May-23-24	Initiated	Deutsche Bank	Buy	$60
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$65
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight	$82
Mar-13-24	Initiated	Raymond James	Outperform	$86
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform
Oct-31-22	Initiated	Guggenheim	Neutral
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$77
Mar-15-22	Initiated	Barclays	Overweight	$53
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$51

Show Previous Ratings

Dec-11-24 07:22AM	Legend Biotechs CARVYKTI® Boosts Myeloma Treatment Success (TipRanks) -5.44%
Dec-09-24 07:35PM	CARVYKTI Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma (GlobeNewswire) -8.96%
04:22PM	Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. (Investor's Business Daily)
Nov-27-24 10:02AM	Why Is Legend Biotech Corp. (LEGN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-22-24 07:31AM	Legend Biotech Corp. (LEGN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts (Insider Monkey)
05:28PM	Loading…
Nov-21-24 05:28PM	Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
Nov-13-24 03:28AM	Q3 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ... (GuruFocus.com)
Nov-12-24 09:30AM	Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:00AM	Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Nov-11-24 09:55AM	Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
07:04AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Nov-07-24 07:30AM	Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-05-24 09:10AM	Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Nov-04-24 07:30AM	Legend Biotech Appoints Alan Bash as President of CARVYKTI (GlobeNewswire)
09:55AM	Loading…
Oct-24-24 09:55AM	Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade (Zacks)
08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results (GlobeNewswire)
Oct-16-24 03:45PM	Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
Oct-03-24 07:30AM	Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)
Sep-30-24 04:11PM	Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% (Investor's Business Daily)
09:46AM	Legend Biotech Rises After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% (Investor's Business Daily)
Sep-27-24 04:35PM	CARVYKTI is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line (GlobeNewswire) +5.17%
04:30PM	Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma (Investor's Business Daily)
Sep-24-24 09:00AM	Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech (Business Wire)
Sep-14-24 07:22PM	Legend Biotech Corporation (LEGN): Among Hedge Funds Top Biotech Stock Picks (Insider Monkey)
Sep-12-24 03:34AM	Heres Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio (Insider Monkey)
Sep-03-24 12:01PM	Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp (GuruFocus.com)
Aug-27-24 10:28AM	GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients (PR Newswire)
Aug-20-24 08:00AM	Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-09-24 07:00AM	Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights (GlobeNewswire)
04:05PM	Loading…
Aug-08-24 04:05PM	Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors (GlobeNewswire)
Jul-29-24 03:24PM	Is Legend Biotech Corporation (LEGN) a Good Growth Stock to Buy? (Insider Monkey)
Jul-26-24 07:00AM	Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024 (GlobeNewswire)
Jul-15-24 09:17AM	Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid (Zacks)
07:39AM	Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains? (Zacks)
Jul-10-24 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results (GlobeNewswire)
Jul-02-24 08:00AM	Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Jun-24-24 08:13AM	Does Legend Biotech (LEGN) Have a Long Runway for Growth? (Insider Monkey)
Jun-20-24 05:26PM	Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike (PR Newswire)
Jun-03-24 04:00PM	Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA (Business Wire)
May-29-24 08:00AM	Legend Biotech to Participate in the Jefferies Global Healthcare Conference (Business Wire)
May-23-24 05:00PM	Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA (Business Wire) -7.28%
May-15-24 08:19AM	Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-14-24 09:23AM	HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating (MT Newswires)
06:54AM	RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating (MT Newswires)
03:01AM	Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ... (GuruFocus.com)
12:20AM	Q1 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-13-24 11:53AM	LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:24AM	Sector Update: Health Care Stocks Decline Pre-Bell Monday (MT Newswires)
08:57AM	Sector Update: Health Care (MT Newswires)
07:30AM	Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell (MT Newswires)
07:00AM	Legend Biotech Reports First Quarter 2024 Results and Recent Highlights (Business Wire)
May-09-24 08:52AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-22-24 01:37PM	Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer (MT Newswires)
01:05PM	CARVYKTI (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma (Business Wire)
Apr-11-24 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results (Business Wire)
Apr-08-24 08:48AM	Why Legend Biotech (LEGN) Stock Might be a Great Pick (Zacks)
Apr-05-24 11:36PM	U.S. FDA approves expanded use of J&J's cancer cell therapy (Reuters)
11:30PM	Legend Biotech's CARVYKTI (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma (Business Wire)
Apr-03-24 05:39AM	Should You Continue to Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Mar-29-24 05:09AM	Management's Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4 (Insider Monkey)
Mar-19-24 08:30AM	Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report (Business Wire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-15-24 03:15PM	CARVYKTI (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma (Business Wire)
Mar-12-24 08:20AM	Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-11-24 07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights (Business Wire)
Feb-23-24 07:15AM	Legend Biotech Announces Positive CHMP Opinion for CARVYKTI (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy (Business Wire) +7.10%
Feb-13-24 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-07-24 02:41AM	Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd (GuruFocus.com)
Jan-22-24 08:34PM	UPDATE 6-US FDA seeks 'boxed warning' for CAR-T cancer therapies (Reuters) +8.17%
08:11PM	US FDA requires 'boxed warning' for CAR-T cancer therapies (Reuters)
08:05AM	Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)? (Insider Monkey)
Jan-03-24 08:30AM	Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
Jan-02-24 10:29AM	Why healthcare, biotech may be top plays for 2024: BTIG (Yahoo Finance Video)
08:30AM	Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-26-23 06:56PM	13 High Growth Healthcare Stocks to Buy (Insider Monkey)
Dec-19-23 11:40AM	5 Most Promising Healthcare Stocks According to Analysts (Insider Monkey)
Dec-11-23 07:30PM	Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI (ciltacabtagene autoleucel) (Business Wire)
Nov-28-23 02:51PM	FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells (The Wall Street Journal)
Nov-24-23 04:02PM	Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-20-23 11:09PM	Q3 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents) -6.29% -5.37%
06:00AM	Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights (Business Wire)
Nov-16-23 05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
Nov-14-23 10:47AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Nov-13-23 08:30AM	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
07:00AM	Novartis licenses Legend cell therapy for lung cancer (BioPharma Dive)
Nov-07-23 08:30AM	Legend Biotech to Host Investor Conference Call on Third-Quarter Results (Business Wire)
Nov-02-23 09:17AM	Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting (Business Wire)
Oct-30-23 10:39AM	Should You Expect Strong Financial Growth from Legend Biotech Corporation (LEGN)? (Insider Monkey)
Oct-20-23 05:10AM	Should You Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Oct-03-23 05:52AM	Legend Biotech Corporation (LEGN)'s Stock Witnessed a 43% Increase in Q2 (Insider Monkey)
Sep-21-23 08:00AM	Blockbuster Cancer Treatment Stymied by Supply Chainfor Now (The Wall Street Journal)
Aug-16-23 02:40AM	Q2 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-15-23 06:00AM	Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights (Business Wire)
Aug-14-23 08:36AM	Why Earnings Season Could Be Great for Legend Biotech (LEGN) (Zacks)
07:15AM	3 Biotech Stocks Poised to Beat Q2 Earnings Estimates (Zacks)
Aug-10-23 08:14AM	Top 5 Stocks Set to Beat on Earnings Next Week (Zacks)
Aug-07-23 06:57PM	3 Biotech Stocks That Analysts Are Drooling Over (InvestorPlace)
Aug-03-23 08:30AM	Legend Biotech to Host Investor Conference Call on Second-Quarter Results (Business Wire)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Heyman Tomas J.	Director	Dec 02 '24	Proposed Sale	43.31	4,366	189,080	Dec 02 03:08 PM
Huang Ying	Officer	Sep 25 '24	Proposed Sale	44.10	1,504	66,326	Sep 25 03:30 PM
Macomber Lori	Officer	Sep 20 '24	Proposed Sale	48.91	90,060	4,405,003	Sep 20 04:43 PM
Yau Wai Man Philip	Director	Sep 20 '24	Proposed Sale	51.04	1,946	99,324	Sep 20 10:46 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your FINVIZ experience